Keywords
hyperthermia
induced
stomach neoplasms
cytoreduction surgical procedures
induction chemotherapy
laparoscopy
Abstract
The gastric cancer with peritoneal metastases still represents a serious problem in the oncological surgery, whereas the peritoneal metastases arising from colorectal cancer can be successfully treated using a multimodal therapy concept consisting of systemic chemotherapy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. The best survival rates in patients suffering from peritoneal metastases of gastric cancer have been reported by the ToGa trial, in patients with HER-2 positive expression who received standard chemotherapy and trastuzumab. Cytoreductive surgery and HIPEC are increasingly wining a place in the multimodal therapy of gastric cancer with peritoneal metastases, the criteria for such an aggressive therapy are strict and the operability needs to be previously assessed by laparoscopic exploration. Interesting new data are awaited from the German GASTRIPEC study and from the French GASTRICHIP study.
References
1. Elias D, Mariani A, Cloutier A, Blot F, Goéré D, Dumont F et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. European Journal of Surgical Oncology (EJSO). 2014;40(11):1467-1473
2. Bang Y, Van Cutsem E, Feyereislova A, Chung H, Shen L, Sawaki A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. The Lancet. 2010;376(9742):687-697.
3. Al-Batran S, Homann N, Pauligk C, Illerhaus G, Martens U, Stoehlmacher J et al. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer. JAMA Oncology. 2017;3(9):1237.
4. Sugarbaker P. Peritonectomy Procedures. Annals of Surgery. 1995;221(1):29-42.
5. Piso P, Leebmann H, März L, Mayr M. Zytoreduktive Chirurgie für maligne Tumoren des Peritoneums. Der Chirurg. 2014;86(1):38-46.
6. Jacquet, P., Sugarbaker, P. H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer treatment and research. 1996;82, 359-374.
7. Chua T, Yan T, Saxena A, Morris D. Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?. Annals of Surgery. 2009;249(6):900-907.
8. Chia C, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K et al. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?. Annals of Surgical Oncology. 2016;23(6):1971-1979.
9. Yang X, Huang C, Suo T, Mei L, Yang G, Cheng F et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial. Annals of Surgical Oncology. 2011;18(6):1575-1581.
10. Rudloff U, Langan R, Mullinax J, Beane J, Steinberg S, Beresnev T et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial. Journal of Surgical Oncology. 2014;110(3):275-284.
11. Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M et al. Outcome Data of Patients with Peritoneal Carcinomatosis from Gastric Origin Treated by a Strategy of Bidirectional Chemotherapy Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Single Specialized Center in Japan. Annals of Surgical Oncology. 2013;21(4):1147-1152.
12. Boerner T, Graichen A, Jeiter T, Zemann F, Renner P, März L et al. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. Annals of Surgical Oncology. 2016;23(12):3972-3977.
13. Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y et al. The 30-year experience—A meta-analysis of randomised and highquality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. European Journal of Cancer. 2017;79:1-14.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2018 Authors